Lake Forest-based Akorn bought by German drug giant for $4.3 billion

Lake Forest-based Akorn bought by German drug giant for $4.3 billion


In just 10 months at the head of Germany's Fresenius, Chief Executive Officer Stephan Sturm has now inked the health-care provider's two biggest-ever deals. With the $4.3 billion acquisition of Lake Forest-based generic drugmaker Akorn, announced late Monday, Fresenius will get a stronger foothold in the U.S., with access to a network of retail pharmacies and outpatient clinics as well as the hospitals where it has traditionally marketed its products.



from Biotech News